Core Conclusions - The report highlights a significant market event where the Shanghai Composite Index surged by 1.38% on the first trading day of 2026, breaking the 4000-point threshold, indicating a strong market sentiment and increased trading volume across A-shares [1] Group 1: Market Signals - Signal One: Transition from "Volume Hesitation" to "Volume Initiation" suggests that the substantial increase in trading volume at the start of the year alleviates concerns about previous low-volume gains. The report anticipates a "re-inflation bull market" driven by the Federal Reserve's interest rate cuts and the appreciation of the RMB, leading to a significant increase in A-share trading volume, with expected lows of 500 billion and 1 trillion in total A-share turnover in September 2024 and June 2025 respectively, confirming the initiation of a major upward trend [1][6] - Signal Two: The report notes a structural thematic and growth market emerging, referred to as the "spring excitement" market, with various themes gaining traction such as brain-machine interfaces, robotics, and commercial aerospace. However, it cautions that sustained high trading volumes may not be realistic, and a potential reduction in volume could lead to a narrowing of thematic trading focus [2] - Signal Three: The insurance sector is identified as a new leader in the bull market, with its recent volume increase confirming the market's upward trend. Historically, insurance has been a key driver in market rallies, and the report suggests a shift from intermediary institutions to asset management institutions as the market transitions from a volatile to a more stable investment environment [3][12] Group 2: Industry Allocation - The report emphasizes the importance of focusing on the insurance sector and a "new high" combination for industry allocation. It suggests that 2025 may be a prelude to a bull market, with 2026 expected to witness the main trend. Key sectors to watch include non-ferrous metals, new consumption (food and beverage/travel), and high-end manufacturing (power equipment/chemicals/healthcare) [4][14]

Group 1 - The report indicates that the Federal Reserve's resumption of interest rate cuts may lead to increased foreign investment in China's export-advantaged assets, particularly in high-end manufacturing sectors such as new energy, chemicals, and pharmaceuticals [1][13] - The "anti-involution" policy in China is expected to enhance the financial returns of the manufacturing sector, with a focus on high-end manufacturing capital expenditure (CAPEX) expansion since 2019, which solidifies global export competitiveness [2][14] - The report suggests that cross-border capital is accelerating its return to China, leading to a "re-inflation bull market" as China's net export scale rises and the RMB enters a long-term appreciation cycle [3][15] Group 2 - The report anticipates a shift in the A-share bull market towards consumption-driven growth, moving from an investment-driven model to one where consumption becomes the primary economic driver [4][16] - It highlights a potential "ice-fire conversion" in market dynamics, where technology sectors may lead the rally, followed by export-oriented high-end manufacturing, and eventually consumer sectors [5][17] Group 3 - The report recommends a stock portfolio for October 2025, including companies such as Dongfang Tower (Chemicals), Huafeng Aluminum (Non-ferrous), China Hongqiao (Non-ferrous), Luoyang Molybdenum (Non-ferrous), Dongfang Tantalum (Non-ferrous), Xinnengda (Electric New), Betta Pharmaceuticals (Pharmaceuticals), Yifeng Pharmacy (Pharmaceutical Retail), Bai'ao Intelligent (Military), Hikvision (Computers), and Luxshare Precision (Electronics) [6][11]

Group 1: Medical Devices Industry - The cardiovascular medical device industry has significant growth potential, with the market for cardiac electrophysiology devices in China expected to grow from CNY 65.80 billion in 2021 to CNY 157.26 billion by 2025, and further to CNY 419.73 billion by 2032 [5][6] - The global market for cardiac rhythm management devices increased from USD 9.7 billion in 2016 to USD 10.6 billion in 2021, with a projected growth to USD 12.8 billion by 2030 [5] - The market for coronary artery disease devices in China is also expanding, with the number of patients expected to reach 31.67 million by 2030, and the market for aortic stent grafts projected to grow significantly [6][7] Group 2: AI Cooling Industry - The AI computing upgrade is driving innovation in cooling technologies, with liquid cooling expected to reduce data center energy consumption by 20%-30%, achieving a PUE below 1.2 [8][9] - The liquid cooling market in China is projected to reach USD 1.26 billion in the first half of 2024, with cold plate solutions currently dominating the market due to their maturity and lower infrastructure modification requirements [9][10] - The market for immersion cooling fluids is expected to grow, with silicone oil and fluorinated liquids being key players, although regulatory challenges may arise [10] Group 3: Semiconductor Industry - Aojie Technology (688220.SH) is a leading player in the baseband chip market, with projected revenues of CNY 45.80 billion, CNY 57.35 billion, and CNY 70.72 billion for 2025, 2026, and 2027 respectively [12][13] - The company has a strong presence in both mobile baseband and IoT sectors, with significant growth expected in its ASIC business, which is anticipated to see multiple-fold growth by 2026 [12][14] Group 4: Pharmaceutical Industry - Lifang Pharmaceutical (003020.SZ) is expected to achieve revenues of CNY 18.53 billion, CNY 22.93 billion, and CNY 27.37 billion from 2025 to 2027, with a strong growth trajectory driven by its unique traditional Chinese medicine products [16][17] - The company is set to launch its first generic version of methylphenidate extended-release tablets in April 2025, targeting a large ADHD market in China [17] Group 5: Beverage Industry - IFBH (6603.HK) is positioned to capture a significant share of the coconut water market in China, which is expected to grow at a CAGR of 55% from 2019 to 2025 [19][20] - The company has established a strong brand presence and is leveraging its supply chain advantages to maintain a competitive edge in the market [20] Group 6: Nonferrous Metals Industry - Zhongmin Resources (002738.SZ) is projected to achieve net profits of CNY 6.03 billion, CNY 12.72 billion, and CNY 22.64 billion from 2025 to 2027, driven by its high-margin cesium and rubidium salt business [22][23] - The company is strategically expanding its copper business, which is expected to provide significant growth potential as demand for copper increases [23][24] Group 7: Aerospace Industry - The commercial aerospace sector is anticipated to reach a turning point with increased satellite launches and the development of reusable rockets, which are critical for the growth of satellite internet [29][30] - Companies like Blue Arrow Aerospace and Tianbing Technology are making significant advancements in rocket technology, with planned launches that could enhance China's capabilities in commercial space [30][31]